Company

Slingshot Biosciences, Inc.

Slingshot Biosciences develops engineered cell mimics for assay validation and quality control.

About

Slingshot Biosciences develops cell mimics used as reference controls for assay validation, including products for cell health, compensation, and calibration. Founded in 2012, the company is based in Emeryville, US. It raised USD 11.230 mn in Series A funding in January 2023, co-led by ARCH Venture Partners, Anterra Capital, and Northpond Ventures.

3Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in